La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
J. B. Chemicals & Pharmaceuticals Bilan de santé
Santé financière contrôle des critères 5/6
J. B. Chemicals & Pharmaceuticals possède un total de capitaux propres de ₹29.2B et une dette totale de ₹3.8B, ce qui porte son ratio d'endettement à 12.9%. Son actif total et son passif total sont ₹39.9B et de ₹10.7B. L'EBIT de J. B. Chemicals & Pharmaceuticals est ₹7.9B ce qui fait que son ratio de couverture des intérêts 24.2. Elle dispose de liquidités et de placements à court terme de ₹4.6B.
Informations clés
12.9%
Ratio d'endettement
₹3.78b
Dette
| Ratio de couverture des intérêts | 24.2x |
| Argent liquide | ₹4.60b |
| Fonds propres | ₹29.23b |
| Total du passif | ₹10.71b |
| Total des actifs | ₹39.94b |
Mises à jour récentes de la santé financière
These 4 Measures Indicate That J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Is Using Debt Reasonably Well
Jun 28
We Think J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Can Stay On Top Of Its Debt
Nov 29Is J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Using Too Much Debt?
Dec 03J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Seems To Use Debt Quite Sensibly
Aug 03Does J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Have A Healthy Balance Sheet?
Mar 29J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Could Easily Take On More Debt
Nov 30Recent updates
Most Shareholders Will Probably Agree With J. B. Chemicals & Pharmaceuticals Limited's (NSE:JBCHEPHARM) CEO Compensation
Aug 15J. B. Chemicals & Pharmaceuticals Limited Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next
Aug 11These 4 Measures Indicate That J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Is Using Debt Reasonably Well
Jun 28J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM) Not Flying Under The Radar
Apr 19J. B. Chemicals & Pharmaceuticals Limited Just Missed Earnings - But Analysts Have Updated Their Models
Feb 09J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM) Not Flying Under The Radar
Dec 22We Think J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Can Stay On Top Of Its Debt
Nov 29J. B. Chemicals & Pharmaceuticals' (NSE:JBCHEPHARM) Dividend Will Be Increased To ₹9.25
Aug 03J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Is Due To Pay A Dividend Of ₹8.50
Feb 11Is J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Using Too Much Debt?
Dec 03A Look At The Intrinsic Value Of J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM)
Sep 21J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Seems To Use Debt Quite Sensibly
Aug 03Estimating The Fair Value Of J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM)
Jun 15Does J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Have A Healthy Balance Sheet?
Mar 29J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Has Re-Affirmed Its Dividend Of ₹8.50
Feb 16With EPS Growth And More, J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Is Interesting
Jan 27J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Could Easily Take On More Debt
Nov 30Here's Why I Think J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Might Deserve Your Attention Today
Sep 24Analyse de la situation financière
Passif à court terme: Les actifs à court terme de JBCHEPHARM ( ₹18.5B ) dépassent ses passifs à court terme ( ₹8.7B ).
Passif à long terme: Les actifs à court terme de JBCHEPHARM ( ₹18.5B ) dépassent ses passifs à long terme ( ₹2.0B ).
Historique et analyse du ratio d'endettement
Niveau d'endettement: JBCHEPHARM dispose de plus de liquidités que de sa dette totale.
Réduire la dette: Le ratio d'endettement de JBCHEPHARM est passé de 1.7% à 12.9% au cours des 5 dernières années.
Couverture de la dette: La dette de JBCHEPHARM est bien couverte par le flux de trésorerie opérationnel ( 208.9% ).
Couverture des intérêts: Les paiements d'intérêts de JBCHEPHARM sur sa dette sont bien couverts par l'EBIT ( 24.2 x couverture).